This review summarizes the historical and evolving role of chemotherapy, including doxorubicin and ifosfamide, in the management of advanced soft-tissue sarcomas.
No takes yet. Share an insight, caveat, or question.
Offers historical perspective on chemotherapy for advanced soft-tissue sarcomas; leaves open optimal integration with novel agents.
Spira et al. (2002) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: